POZ - Treatment News : Better Antibiotics for Second-Line PCP Treatment
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2008

Special Reports

Rallying Behind HIV Vaccine Research

The Mother of All Battles

Face and Butt, Heal Thyselves

» More

Most Talked About

An HIV Doc's Dilemma (38)

Virtual Prevention: Fighting HIV Online (26)

HIV-Positive Man Sentenced to 35 Years for Spitting (20)

Face and Butt, Heal Thyselves (15)

Lambda Legal Responds to HIV Spitting Conviction (15)

Most Popular Lessons

Herpes Simplex Virus

Syphilis & Neurosyphilis

Shingles

The HIV Life Cycle

Human Papilloma Virus (HPV)

10 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

April 28, 2008

Better Antibiotics for Second-Line PCP Treatment

A combination of two oral antibiotics is more effective than the commonly used, yet side effect-prone, intravenous pentamidine for people who’ve failed their first AIDS-related pneumonia regimen, according to the authors of a new study published in the May 1 issue of the Journal of Acquired Immune Deficiency Syndromes (JAIDS). Data supporting the use of clindamycin and primaquine is promising news for the roughly 10 percent of patients whose first course of treatment for Pneumcystis jirovecii pneumonia (PCP) doesn’t work.

Intravenous pentamidine is known for a range of serious side effects, including kidney toxicity, low blood pressure and low white blood cell count, and has been shown less effective as treatment for PCP than the antibiotic trimethoprim-sulfamethoxazole (TMP-SMX), commonly known as Bactrim or Septra. For this reason, pentamidine is typically recommended only as second-line therapy for those who don’t respond effectively to their initial treatment choice, or as first-line treatment for people who cannot tolerate TMP-SMX. There are alternatives to pentamidine, but there has been little research to show how effective they may be in treating people who fail their first PCP regimen.

Thomas Benfield, MD, DMSci, from the Department of Infectious Diseases at Hvidovre University Hospital in Copenhagen, Denmark, and his colleagues conducted an analysis of 29 published studies, plus an additional 82 case reports from three European cities. In all, they were able to study the outcomes of 468 second-line PCP treatment episodes.

Benfield’s team found intravenous pentamidine was effective 44 percent of the time in curing cases of PCP in people who’d failed their first treatment. However, the cure rate was far higher (73 percent) in people who took clindamycin and primaquine, which are also less likely to cause serious side effects than pentamidine.

Benfield’s group recommends that clindamycin-primaquine now be used as second-line treatment in people with PCP who fail on TMP-SMX, or who cannot tolerate TMP-SMX.

Search: pentamidine, trimethoprim, sulfamethoxazole, TMP-SMX, Bactrim, Septra, clindamycin, primaquine, Thomas, Benfield, Hvidovre, University, pnumocystis, jerovecii, pneumonia, PCP


Scroll down to comment on this story.

emailrssprint

Name:

(2-50 characters)

Email:

(will not show)

City:

(optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

         


[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Do you suffer from allergies?
Yes
No

Monthly Poll
Question: Why are women being diagnosed so late that they have progressed to AIDS by the time of their diagnosis?
Women are too busy taking care of other family members
Doctors aren't testing
Doctors are unaware that a woman's symptoms can differ from a man's
Fear of HIV stigma
Denial
Women's lack of empowerment

Surveys
How do you see America's place in the global AIDS epidemic?

Tell us your political opinions on HIV/AIDS

more surveys  
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy